SCHEMBL4590086

SCHEMBL4590086

O=COc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 5/20 0.57
TSHR P16473 1/20 0.57
NR1H2 P55055 1/20 0.50
BAX Q07812 1/20 0.50
MAOA P21397 1/20 0.50
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
GSTP1 P09211 1/20 0.47
SOS1 Q07889 1/20 0.47
CA9 Q16790 1/20 0.47
PARP10 Q53GL7 1/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
KMT2A Q03164 1/20 0.47
SRD5A2 P31213 1/20 0.45
AKR1B1 P15121 1/20 0.44
HPGD P15428 1/20 0.44
TLR4 O00206 1/20 0.44
TLR2 O60603 1/20 0.44
MGLL Q99685 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9809027 0.90 ALDH1A1 (0.41) LTA4HTSHRNR1H2BAXMAOA
Formic Acid Phenyl Ester SCHEMBL2662 0.90
SCHEMBL5049780 0.90 ALDH1A1 (0.41) LTA4HTSHRNR1H2BAXMAOA
Formic Acid Phenyl Ester SCHEMBL28837141 0.87 TSHR (0.43) LTA4HTSHRNR1H2BAXMAOA
Formic Acid Phenyl Ester SCHEMBL10906188 0.87 TSHR (0.43) LTA4HTSHRNR1H2BAXMAOA
Formic Acid Phenyl Ester SCHEMBL5423511 0.87 TSHR (0.43) LTA4HTSHRNR1H2BAXMAOA
Formic Acid Phenyl Ester SCHEMBL29287814 0.87 TSHR (0.43) LTA4HTSHRNR1H2BAXMAOA
Formic Acid Phenyl Ester SCHEMBL29726513 0.87 TSHR (0.43) LTA4HTSHRNR1H2BAXMAOA
Formic Acid Phenyl Ester SCHEMBL10903642 0.87 TSHR (0.43) LTA4HTSHRNR1H2BAXMAOA
SCHEMBL14480072 0.85 MAOB (0.50) LTA4HTSHRMAOAGSTP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109562185-A Novel conjugates of agents and moieties capable of binding to glucose-sensing proteins 赛诺菲 2019-04-02 CN disclosed
EP-1966288-A1 CROSSLINKED POLYMER FILM BEARING IONIC GROUPINGS INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) 2008-09-10 EP disclosed
WO-2007060321-A1 CROSSLINKED POLYMER FILM BEARING IONIC GROUPINGS INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) 2007-05-31 WO disclosed
US-20020147188-A1 Protease inhibitors SMITHKLINE BEECHAM CORPORATION 2002-10-10 US disclosed
US-5952506-A Process for the synthesis of 4- 6- (hexylcarbamoyloxy) hexylcarbamoyloxy!-piperidine-1-carboxylic acid 4-phenoxyphenyl ester AMERICAN HOME PRODUCTS CORPORATION (US) 1999-09-14 US disclosed
WO-1998047870-A1 PROCESS FOR THE SYNTHESIS OF 4-[6-(HEXYLCARBAMOYLOXY) HEXYLCARBAMOYLOXY]-PIPERIDINE-1- CARBOXYLIC ACID 4-PHENOXYPHENYL ESTER AMERICAN HOME PRODUCTS CORPORATION (US) 1998-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020147188-A1 Protease inhibitors CTSK, MMP13, CTSZ LTA4H 578/4885TSHR 4016/4885NR1H2 4382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.